▶ 調査レポート

脂質API(有効成分)の世界市場2020

• 英文タイトル:Global Lipids Active Pharmaceutical Ingredient Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Globalinforesearchが調査・発行した産業分析レポートです。脂質API(有効成分)の世界市場2020 / Global Lipids Active Pharmaceutical Ingredient Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / MRC0921938資料のイメージです。• レポートコード:MRC0921938
• 出版社/出版日:Globalinforesearch / 2020年8月
• レポート形態:英文、PDF、127ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:製薬
• 販売価格(消費税別)
  Single User¥372,360 (USD3,480)▷ お問い合わせ
  Corporate License¥744,720 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要

According to our latest research, the global Lipids Active Pharmaceutical Ingredient size is estimated to be xx in 2020 from USD XX million in 2019, with a change xx% between 2019 and 2020. The global Lipids Active Pharmaceutical Ingredient market size is expected to grow at xx % or more annually for the next five years.
The Lipids Active Pharmaceutical Ingredient market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
This report also the impact of Covid-19 outbreak on the Lipids Active Pharmaceutical Ingredient industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Lipids Active Pharmaceutical Ingredient and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

[Market Segmentation]
Lipids Active Pharmaceutical Ingredient market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market Segment by Type, covers
 Phospholipids API
 Cholesterol API
 Fatty Acids API
 Others

Market Segment by Application can be divided into
 Cardiovascular Diseases
 Inflammatory Disease
 Diabetes
 Other

The key market players for global Lipids Active Pharmaceutical Ingredient market are listed below:
 CordenPharma
 Esperion Therapeutics
 Avanti Polar Lipids (Croda)
 Merck KGaA
 Yuwang Group
 Guangzhou Hanfang Pharmaceutical Co.,Ltd

Market segment by regions, regional analysis covers
 North America (United States, Canada, and Mexico)
 Europe (Germany, France, United Kingdom, Russia, and Italy)
 Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
 South America (Brazil, Argentina, Colombia)
 Middle East & Africa (Saudi Arabia, UAE, Egypt, and South Africa)

レポート目次

1 Market Overview
1.1 Lipids Active Pharmaceutical Ingredient Introduction
1.1.1 COVID-19 Impact Insights
1.1.2 COVID-19 Impact Assessment
1.2 Market Analysis by Type
1.2.1 Overview: Global Lipids Active Pharmaceutical Ingredient Revenue by Type: 2020 Versus 2025
1.2.2 Phospholipids API
1.2.3 Cholesterol API
1.2.4 Fatty Acids API
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Lipids Active Pharmaceutical Ingredient Revenue by Application: 2020 Versus 2025
1.3.2 Cardiovascular Diseases
1.3.3 Inflammatory Disease
1.3.4 Diabetes
1.3.5 Other
1.4 Overview of Global Lipids Active Pharmaceutical Ingredient Market
1.4.1 Global Lipids Active Pharmaceutical Ingredient Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 COVID-19 Impact on Global Economy
1.5.1 COVID-19 Impact on Global GDP
1.5.2 COVID-19 Impact on World Merchandise Trade
1.5.3 COVID-19 Impact on Commodity prices
1.6 Market Trends, Opportunities and Restraints
1.6.1 Growth Opportunities Analysis in Covid-19 Crisis
1.6.2 Market Risk and Restraints
1.6.3 Market Growth Drivers
2 Manufacturers Profiles
2.1 CordenPharma
2.1.1 CordenPharma Details
2.1.2 CordenPharma Major Business
2.1.3 CordenPharma SWOT Analysis
2.1.4 CordenPharma Lipids Active Pharmaceutical Ingredient Product and Services
2.1.5 CordenPharma Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Esperion Therapeutics
2.2.1 Esperion Therapeutics Details
2.2.2 Esperion Therapeutics Major Business
2.2.3 Esperion Therapeutics SWOT Analysis
2.2.4 Esperion Therapeutics Lipids Active Pharmaceutical Ingredient Product and Services
2.2.5 Esperion Therapeutics Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Avanti Polar Lipids (Croda)
2.3.1 Avanti Polar Lipids (Croda) Details
2.3.2 Avanti Polar Lipids (Croda) Major Business
2.3.3 Avanti Polar Lipids (Croda) SWOT Analysis
2.3.4 Avanti Polar Lipids (Croda) Lipids Active Pharmaceutical Ingredient Product and Services
2.3.5 Avanti Polar Lipids (Croda) Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck KGaA
2.4.1 Merck KGaA Details
2.4.2 Merck KGaA Major Business
2.4.3 Merck KGaA SWOT Analysis
2.4.4 Merck KGaA Lipids Active Pharmaceutical Ingredient Product and Services
2.4.5 Merck KGaA Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Yuwang Group
2.5.1 Yuwang Group Details
2.5.2 Yuwang Group Major Business
2.5.3 Yuwang Group SWOT Analysis
2.5.4 Yuwang Group Lipids Active Pharmaceutical Ingredient Product and Services
2.5.5 Yuwang Group Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Guangzhou Hanfang Pharmaceutical Co.,Ltd
2.6.1 Guangzhou Hanfang Pharmaceutical Co.,Ltd Details
2.6.2 Guangzhou Hanfang Pharmaceutical Co.,Ltd Major Business
2.6.3 Guangzhou Hanfang Pharmaceutical Co.,Ltd Lipids Active Pharmaceutical Ingredient Product and Services
2.6.4 Guangzhou Hanfang Pharmaceutical Co.,Ltd Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Lipids Active Pharmaceutical Ingredient Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Lipids Active Pharmaceutical Ingredient Manufacturer Market Share
3.3.2 Top 6 Lipids Active Pharmaceutical Ingredient Manufacturer Market Share
3.4 Market Competition Trend
4 Market Analysis by Regions
4.1 Global Lipids Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Regions
4.1.1 Global Lipids Active Pharmaceutical Ingredient Sales and Market Share by Regions (2015-2020)
4.1.2 Global Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Regions (2015-2020)
4.2 North America Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
4.3 Europe Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
4.5 South America Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Lipids Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Country
5.1.1 North America Lipids Active Pharmaceutical Ingredient Sales and Market Share by Country (2015-2020)
5.1.2 North America Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Country (2015-2020)
5.2 United States Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
5.3 Canada Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
5.4 Mexico Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Lipids Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Country
6.1.1 Europe Lipids Active Pharmaceutical Ingredient Sales and Market Share by Country (2015-2020)
6.1.2 Europe Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Country (2015-2020)
6.2 Germany Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.3 United Kingdom Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.4 France Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.5 Russia Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.6 Italy Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Region
7.1 Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Region
7.1.1 Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales and Market Share by Region (2015-2020)
7.1.2 Asia-Pacific Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Region (2015-2020)
7.2 China Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.3 Japan Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.4 Korea Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.5 India Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.7 Australia Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Lipids Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Country
8.1.1 South America Lipids Active Pharmaceutical Ingredient Sales and Market Share by Country (2015-2020)
8.1.2 South America Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Country (2015-2020)
8.2 Brazil Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
8.3 Argentina Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Country
9.1 Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9.3 Turkey Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9.4 Egypt Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9.5 South Africa Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Lipids Active Pharmaceutical Ingredient Sales and Market Share by Type (2015-2020)
10.2 Global Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Type (2015-2020)
10.3 Global Lipids Active Pharmaceutical Ingredient Price by Type (2015-2020)
11 Market Segment by Application
11.1 Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
11.2 Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Application (2015-2020)
11.3 Global Lipids Active Pharmaceutical Ingredient Price by Application (2015-2020)
12 Market Forecast
12.1 Lipids Active Pharmaceutical Ingredient Market Forecast by Regions (2020-2025)
12.1.1 North America Lipids Active Pharmaceutical Ingredient Market Forecast (2020-2025)
12.1.2 Europe Lipids Active Pharmaceutical Ingredient Market Forecast (2020-2025)
12.1.3 Asia-Pacific Lipids Active Pharmaceutical Ingredient Market Forecast (2020-2025)
12.1.4 South America Lipids Active Pharmaceutical Ingredient Market Forecast (2020-2025)
12.1.5 Middle East & Africa Lipids Active Pharmaceutical Ingredient Market Forecast (2020-2025)
12.2 Lipids Active Pharmaceutical Ingredient Market Forecast by Type (2020-2025)
12.2.1 Global Lipids Active Pharmaceutical Ingredient Sales Forecast by Type (2020-2025)
12.2.2 Global Lipids Active Pharmaceutical Ingredient Market Share Forecast by Type (2020-2025)
12.3 Lipids Active Pharmaceutical Ingredient Market Forecast by Application (2020-2025)
12.3.1 Global Lipids Active Pharmaceutical Ingredient Sales Forecast by Application (2020-2025)
12.3.2 Global Lipids Active Pharmaceutical Ingredient Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Channel
13.1.2 Indirect Channel
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer